FlawCheck Citator
Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10339225
United States Court of Appeals for the Fourth Circuit

Tigress McDaniel v. Sun Pharmaceutical Industries Ltd.

No. 10339225 · Decided February 24, 2025
No. 10339225 · Fourth Circuit · 2025 · FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Fourth Circuit
Decided
February 24, 2025
Citation
No. 10339225
Disposition
See opinion text.
Full Opinion
USCA4 Appeal: 24-2002 Doc: 7 Filed: 02/24/2025 Pg: 1 of 2 UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 24-2002 TIGRESS SYDNEY ACUTE MCDANIEL, Plaintiff - Appellant, v. SUN PHARMACEUTICAL INDUSTRIES LTD.; SUN PHARMACEUTICAL INDUSTRIES, INC.; SUN PHARMACEUTICAL MEDICARE LIMITED; CVS PHARMACY, INC.; DOES, Defendants - Appellees. Appeal from the United States District Court for the Western District of North Carolina, at Charlotte. Graham C. Mullen, Senior District Judge. (3:24-cv-00823-GCM) Submitted: February 20, 2025 Decided: February 24, 2025 Before AGEE, HARRIS, and RUSHING, Circuit Judges. Dismissed by unpublished per curiam opinion. Tigress Sydney Acute McDaniel, Appellant Pro Se. Unpublished opinions are not binding precedent in this circuit. USCA4 Appeal: 24-2002 Doc: 7 Filed: 02/24/2025 Pg: 2 of 2 PER CURIAM: Tigress Sydney Acute McDaniel seeks to appeal the district court’s September 16, 2024, text order denying McDaniel’s motion to strike language from a prior court order. This court may exercise jurisdiction only over final orders, 28 U.S.C. § 1291, and certain interlocutory and collateral orders, 28 U.S.C. § 1292; Fed. R. Civ. P. 54(b); Cohen v. Beneficial Indus. Loan Corp., 337 U.S. 541, 545-46 (1949). The order that McDaniel seeks to appeal is neither a final order, given that litigation on her claims is ongoing, nor is it an appealable interlocutory or collateral order. Accordingly, we dismiss this appeal for lack of jurisdiction. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process. DISMISSED 2
Plain English Summary
USCA4 Appeal: 24-2002 Doc: 7 Filed: 02/24/2025 Pg: 1 of 2 UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No.
Key Points
Frequently Asked Questions
USCA4 Appeal: 24-2002 Doc: 7 Filed: 02/24/2025 Pg: 1 of 2 UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No.
FlawCheck shows no negative treatment for Tigress McDaniel v. Sun Pharmaceutical Industries Ltd. in the current circuit citation data.
This case was decided on February 24, 2025.
Use the citation No. 10339225 and verify it against the official reporter before filing.
Why Attorneys Choose FlawFinder

Why Attorneys Choose FlawFinder

Side-by-side with Westlaw and LexisNexis

Feature FlawFinder Westlaw LexisNexis
Monthly price$19 – $99$133 – $646$153 – $399
ContractNone1–3 year min1–6 year min
Hidden fees$0, alwaysUp to $469/search$25/mo + per-doc
FlawCheck citatorIncludedKeyCite ($$$)Shepard's ($$$)
Plain-English summaryIncludedNoNo
CancelOne clickTermination feesAccount friction
Related Cases

Full legal research for $19/month

All 50 states · Federal regulations · Case law · Police SOPs · AI analysis included · No contract

Continue Researching →